[Federal Register: April 15, 1998 (Volume 63, Number 72)] [Notices] [Page 18432] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr15ap98-110] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Cancer Institute Special Emphasis Panel (SEP) meeting: Name of SEP: Phase II Study of Arsenic Trioxide in Leukemia Telephone Conference Call. Date: April 27, 1998. Time: 12:30 p.m. to Adjournment. Place: National Cancer Institute, Executive Plaza North, Room 635C, 6130 Executive Boulevard, Bethesda, MD 20892. Contact Person: David Irwin, Ph.D., Scientific Review Administrator, National Cancer Institute, NIH, Executive Plaza North, Room 635C, 6130 Executive Boulevard, MSC 7408, Bethesda, MD 20892-7408, Telephone: 301/402-0371. Purpose/Agenda: To review, discuss and evaluate grant applications. This notice is being published less than 15 days prior to the meeting due to the urgent need to meet timing limitations imposed by the review and funding cycle. The meeting will be closed in accordance with the provisions set forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. (Catalog of Federal Domestic Assistance Program Numbers: 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control) Dated: April 9, 1998. LaVerne Y. Stringfield, Committee Management Officer, NIH. [FR Doc. 98-9983 Filed 4-14-98; 8:45 am] BILLING CODE 4140-01-M